You are here
Clinical Trials: Eye Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Retinitis Pigmentosa
Interventions: Biological: Intravitreal injection of Autologous bone marrow Stem Cell; Other: Subconjunctival injection of saline
Sponsors: Red de Terapia Celular; Spanish National Health System; Hospital Universitario Virgen de la Arrixaca; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Public Health Service, Murcia; Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Recruiting - verified September 2015
Interventions: Biological: Intravitreal injection of Autologous bone marrow Stem Cell; Other: Subconjunctival injection of saline
Sponsors: Red de Terapia Celular; Spanish National Health System; Hospital Universitario Virgen de la Arrixaca; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Public Health Service, Murcia; Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Recruiting - verified September 2015
Conditions: Corneal Disease; Pterygium; Myopia; Hyperopia
Interventions: Procedure: LSCs and amniotic membrane (Modified Technique); Procedure: Amniotic membrane only (Traditional Technique); Procedure: PRK, LSCs, and amniotic membrane (Modified Technique); Procedure: PRK only (Traditional Technique); Drug: Levofloxacin; Drug: Betamethasone; Drug: Limbal stem cells (LSCs)
Sponsor: Sun Yat-sen University
Recruiting - verified May 2014
Interventions: Procedure: LSCs and amniotic membrane (Modified Technique); Procedure: Amniotic membrane only (Traditional Technique); Procedure: PRK, LSCs, and amniotic membrane (Modified Technique); Procedure: PRK only (Traditional Technique); Drug: Levofloxacin; Drug: Betamethasone; Drug: Limbal stem cells (LSCs)
Sponsor: Sun Yat-sen University
Recruiting - verified May 2014
Condition: Myopic Macular Degeneration
Intervention: Biological: MA09-hRPE Cellular Therapy
Sponsors: University of California, Los Angeles; Ocata Therapeutics
Recruiting - verified February 2016
Intervention: Biological: MA09-hRPE Cellular Therapy
Sponsors: University of California, Los Angeles; Ocata Therapeutics
Recruiting - verified February 2016
Conditions: Diabetes; Diabetic Retinopathy
Interventions: Drug: Fenofibrate 145 mg; Drug: Placebo
Sponsors: University of Padova; Azienda Ospedaliera di Padova
Recruiting - verified December 2014
Interventions: Drug: Fenofibrate 145 mg; Drug: Placebo
Sponsors: University of Padova; Azienda Ospedaliera di Padova
Recruiting - verified December 2014
Conditions: Retinal Disease; Macular Degeneration; Hereditary Retinal Dystrophy; Optic Nerve Disease; Glaucoma
Interventions: Procedure: RB (Retrobulbar); Procedure: ST (Subtenon); Procedure: IV (Intravenous); Procedure: IVIT (Intravitreal); Procedure: IO (Intraocular)
Sponsors: Retina Associates of South Florida; MD Stem Cells
Recruiting - verified January 2016
Interventions: Procedure: RB (Retrobulbar); Procedure: ST (Subtenon); Procedure: IV (Intravenous); Procedure: IVIT (Intravitreal); Procedure: IO (Intraocular)
Sponsors: Retina Associates of South Florida; MD Stem Cells
Recruiting - verified January 2016
Condition: Retinitis Pigmentosa
Intervention: Biological: BMMNCs
Sponsor: Chaitanya Hospital, Pune
Recruiting - verified September 2014
Intervention: Biological: BMMNCs
Sponsor: Chaitanya Hospital, Pune
Recruiting - verified September 2014
Condition: Age Related Macular Degeneration
Intervention: Drug: autologous bone marrow derived stem cells
Sponsors: Al-Azhar University; Hassan , Hosny , M.D. M.Sc; Samour , Hany M.D. M.Sc; Ismail , Mahmoud M.D. M.Sc; Higazy , Hasan M.D. M.Sc; Abou el kheir, Wael, M.D. M.Sc.; Gabr, Hala , M.D. M.Sc.; Bakry, Sayed , phD. M.Sc.
Recruiting - verified December 2013
Intervention: Drug: autologous bone marrow derived stem cells
Sponsors: Al-Azhar University; Hassan , Hosny , M.D. M.Sc; Samour , Hany M.D. M.Sc; Ismail , Mahmoud M.D. M.Sc; Higazy , Hasan M.D. M.Sc; Abou el kheir, Wael, M.D. M.Sc.; Gabr, Hala , M.D. M.Sc.; Bakry, Sayed , phD. M.Sc.
Recruiting - verified December 2013
Condition: Optic Atrophy
Intervention: Biological: STEM CELL THERAPY
Sponsor: Chaitanya Hospital, Pune
Recruiting - verified September 2014
Intervention: Biological: STEM CELL THERAPY
Sponsor: Chaitanya Hospital, Pune
Recruiting - verified September 2014
Condition: Ischemia
Intervention: Biological: Intravitreal Bone Marrow Stem Cells
Sponsor: University of Sao Paulo
Recruiting - verified January 2014
Intervention: Biological: Intravitreal Bone Marrow Stem Cells
Sponsor: University of Sao Paulo
Recruiting - verified January 2014
Conditions: Retinitis Pigmentosa; Usher Syndrome Type 2; Usher Syndrome Type 3
Intervention: Drug: NT-501
Sponsors: Neurotech Pharmaceuticals; University of California, San Francisco; FDA Office of Orphan Products Development
Recruiting - verified March 2016
Intervention: Drug: NT-501
Sponsors: Neurotech Pharmaceuticals; University of California, San Francisco; FDA Office of Orphan Products Development
Recruiting - verified March 2016
